Ticker

No recent analyst price targets found for PCF.

Latest News for PCF

PCF: Dividend And NAV Are Likely To Trend Lower (Rating Downgrade)

High Income Securities Fund is downgraded to a sell due to persistent NAV erosion and unsustainable distributions. PCF trades at a 12.63% discount to NAV, but this reflects ongoing earnings and dividend sustainability challenges. Net investment income remains insufficient to cover the 12.1% yield, with payouts exceeding earnings and accelerating capital erosion.

Seeking Alpha • May 2, 2026
PCF: Deep Discount With Discounted Portfolio Exposure

The High Income Securities Fund offers deep diversification via a sleeve of fund-of-funds exposure, currently trading at a -11.50% discount to NAV. PCF's expense ratio is fairly high, which is compounded by underlying CEF and BDC fees, but the fund's discount-on-discount structure creates tactical appeal. The managed 10% distribution policy has led to payout reductions over time, but with the current yield at…

Seeking Alpha • Feb 12, 2026
Samsung Biologics leads climate transparency with independent validation of Product Carbon Footprint system

Samsung Biologics' PCF system validated in line with globally established ISO and PAS standards Validation reflects continued efforts to establish credible carbon accounting in support of net-zero goals Validated system provides reliable, consistent carbon footprint data for clients INCHEON, South Korea, Feb. 6, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing…

PRNewsWire • Feb 6, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for PCF.

No House trades found for PCF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top